The NTAGI is Considering Giving Immunocompromised Persons a “Additional” Dosage of COVID-19 Vaccination.
Synopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
Synopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
Synopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
Australian biotech giant CSL is negotiating with Vifor Pharma Group to acquire the Swiss company for A$10 billion ($7.1 billion), says the…
Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…
Secarna to receive an upfront along with an option exercise fees & is also eligible to receive development & commercial milestone along…
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of…
Bangladesh’s Beximco Pharmaceuticals announced that it will begin selling generic versions of Merck’s Covid-19 antiviral drug with local regulatory approval. The announcement…
Drug firm Zydus Cadila on Monday said it has received an order to supply one crore doses of its Covid-19 vaccine, ZyCoV-D,…
SUMMARY: Janssen’s ICEBERG study has demonstrated that Esketamine nasal spray (NS) has shown improved outcomes in an indirect treatment comparison with other…
KEYPOINTS; Antengene Corporation Limited announced that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for…